✦ LIBER ✦

The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL)

✍ Scribed by Katarina Junevik; Olle Werlenius; Sverker Hasselblom; Stefan Jacobsson; Herman Nilsson-Ehle; Per-Ola Andersson

Publisher: Springer
Year: 2006
Tongue: English
Weight: 232 KB
Volume: 86
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-006-0198-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T-cell CD38 expression in B-chronic lymp

T-cell CD38 expression in B-chronic lymphocytic leukaemia

✍ Nashwa Khayrat Abousamra; Manal Salah EL-Din; Emad Azmy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

## Abstract B‐cell chronic lymphocytic leukaemia (B‐CLL) is a heterogeneous disease with some patients having an indolent course never needs treatment, while others having rapidly progressive one requires intensive treatment. In recent decades, numerous prognostic markers, such as immunoglobulin va

Aberrant expression of TRAIL in B chroni

Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells

✍ Paola Secchiero; Mario Tiribelli; Elisa Barbarotto; Claudio Celeghini; Angela Mi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB 👁 2 views

Analysis of peripheral blood (>85% CD19+/CD5+ B) lymphocytes, obtained from 44 patients affected by B chronic lymphoid leukemia (B-CLL), showed that surface TNF-related apoptosis inducing ligand (TRAIL) was expressed in all samples and at higher levels with respect to unfractionated lymphocytes and

Different schemes of B-cell chronic lymp

Different schemes of B-cell chronic lymphocytic leukaemia (B-CLL) treatment in the population affected by the Chernobyl accident

✍ Oksana M. Polyshchuk; Iryna S. Dyagil; Viktor I. Klymenko; Dimitry A. Bazyka; Ir 📂 Article 📅 2005 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 121 KB

## Background Remarkable advance in the knowledge of the biology and treatment of chronic lymphocytic leukaemia (CLL) has been noted in recent years. CLL resembles several heterogeneous diseases with variable morphological features. New agents with antileukemic activity have been introduced recent

Chronic lymphocytic leukaemia (CLL) and

Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing

✍ Andy C. Rawstron; Jane Shingles; Ruth de Tute; Fiona Bennett; Andrew S. Jack; Pe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

CD38 as a prognostic factor in B cell ch

CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): Comparison of three approaches to analyze its expression

✍ Joke G. Boonstra; Kirsten van Lom; Anton W. Langerak; Wilfried J. Graveland; Pet 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 1 views

## Abstract ## Background: Increased CD38 expression by leukemic cells has been suggested as an adverse prognostic factor in B‐CLL. Several approaches have been proposed to quantify its level of expression by flow cytometry. ## Methods: We compared the use of (i) the percentage of CD38 positive

Mycosis fungoides and chronic lymphocyti

Mycosis fungoides and chronic lymphocytic leukaemia – composite T-cell and B-cell lymphomas presenting in the skin

✍ P.R. Hull; A. Saxena 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Composite lymphomas involving cutaneous B-cell and T-cell lymphomas are very uncommon. We report here the unique circumstance of a patient with mycosis fungoides (primary cutaneous T-cell lymphoma) who later developed chronic lymphocytic leukaemia (B-cell lymphoproliferation, B-CLL), which presented